Using a drug-coated balloon for treating blocked coronary arteries
Official title: Drug-Coated Balloon in Native Chronic Total Occlusion Percutaneous Coronary Intervention (IMAGINATION)
Run by National Institute of Cardiology, Warsaw, Poland · NCT06275386 · Data updated 2026-11-12
This study is testing whether a drug-coated balloon can safely help people with blocked coronary arteries feel better during a heart procedure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | National Institute of Cardiology, Warsaw, Poland Academic / other |
| Locations | 1 site (Warsaw, Masovian Voivodeship) |
| Status | Recruiting |
| Started | March 24, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | May 2026 |
| Registry record updated | January 2, 2026 |
| Trial ID | NCT06275386 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are symptomatic patients with a native chronic total occlusion who meet specific clinical criteria for PCI.
✕Probably not a fit
Patients with conditions such as myocardial infarction, severe valvular disease, or those who are not suitable for PCI will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The IMAGINATION trial is a prospective, single-center investigation focusing on symptomatic patients with chronic total occlusion (CTO) of coronary arteries. It aims to evaluate the efficacy and safety of a drug-coated balloon (DCB) during percutaneous coronary intervention (PCI) guided by intravascular ultrasound (IVUS). Patients will undergo baseline assessments and follow-up evaluations at 6 and 12 months to assess the outcomes of the DCB treatment. The study seeks to provide insights that could lead to future randomized trials comparing DCB to traditional drug-eluting stents.
Why it matters
Potential benefit: If successful, this approach could offer a safer and more effective treatment option for patients with chronic total occlusion of coronary arteries.
How similar studies have gone: While there have been advancements in CTO PCI techniques, the specific use of drug-coated balloons for this purpose is still being explored and has not been widely tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * clinical indication for CTO PCI as determined by the local heart team (presence of angina or equivalent symptoms and/or documented ischemia or viability) * native CTO lesion as defined by invasive coronary angiography * informed consent for participation in the study Exclusion Criteria: * \<18 years of age * myocardial infarction * cardiogenic shock * severe valvular disease * estimated life expectancy \<1 year * contraindication to PCI * positive pregnancy test or breast-feeding * in-stent CTO * CTO recanalization using antegrade or retrograde dissection and re-entry techniques
Where it's running
-
National Institute of Cardiology
Warsaw, Masovian Voivodeship, Poland Recruiting
Study contacts
- Principal investigator: Maksymilian Opolski — National Institute of Cardiology
- Study coordinator: Maksymilian Opolski
- Email: mopolski@ikard.pl
- Phone: 0048(22)3434127
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.